To view this email as a web page, click here.
 
Generic EpiPen poised to alleviate shortages
FDA approved the first generic version of epinephrine (EpiPen and EpiPen Jr), which may help alleviate the current shortage of EpiPen in certain areas of the United States.
Read more
 
Novel gene-silencing drug holds promise for this rare disease
FDA okayed a first-of-its-kind gene-silencing drug to treat a rare disease.
Read more
 
Broader indication for prostate cancer drug could net billions of dollars
FDA's approval of an expanded indication for a prostate cancer drug could net 2 pharmaceutical manufacturers billions of dollars.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.